Toru Yoshinari
Toru Yoshinari publishes mostly in Rheumatology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments.
- World rank
- #1,284,226 of 7,710,434 ranked researchers
- Rank in ??
- #1,719 of 21,892
- Works
- 32
- Citations
- 1.1k
- Citations per work
- 33.5
What does Toru Yoshinari research?
Toru Yoshinari's work is mostly in Medicine (76%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2476.4%
- Medicine2476.4%
- Everything else823.6%
- 1Rheumatology43% of their works
- 2Endocrinology, Diabetes and Metabolism10% of their works
- 3Radiology, Nuclear Medicine and Imaging8% of their works
- 4Genetics6% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Surgery4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Monoclonal and Polyclonal Antibodies Research
- Chronic Lymphocytic Leukemia Research
- Diabetes Management and Research
- Diabetes Treatment and Management
- Autoimmune and Inflammatory Disorders Research
Which keywords describe Toru Yoshinari's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Glycemic Control and Insulin Therapy.
- Juvenile Idiopathic Arthritis
- Hemophagocytic Lymphohistiocytosis
- Cardiovascular Outcomes
- Chronic Lymphocytic Leukemia
- Fc Receptors
- Insulin Therapy
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Glycemic Control
- Spondyloarthritis
- Therapeutic Antibodies
- Genomic Aberrations
- Diabetes
- Hypoglycemia
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies312 topics
- Inflammation201 topic
- Rheumatoid Arthritis201 topic
- Antiphospholipid Syndrome111 topic
- Systemic Lupus Erythematosus111 topic
- Ankylosing Spondylitis81 topic
- Glycemic Control82 topics
- Insulin Therapy82 topics
- Spondyloarthritis81 topic
- Fc Receptors71 topic
- Therapeutic Antibodies71 topic
- Chronic Lymphocytic Leukemia61 topic
- Genomic Aberrations61 topic
- Cardiovascular Outcomes41 topic
- Diabetes41 topic
- Hemophagocytic Lymphohistiocytosis41 topic
- Hypoglycemia41 topic
- Juvenile Idiopathic Arthritis41 topic
- Type 2 Diabetes41 topic
Where does Toru Yoshinari work?
Toru Yoshinari's main affiliation in the publication record is Mitsubishi Tanabe Pharma Corporation, ??.
How many publications and citations does Toru Yoshinari have?
OpenAlex counts 32 works and 1,071 citations for Toru Yoshinari, an h-index of 13, ranking #1,284,226 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Toru Yoshinari. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.